Gunther Verween

Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

Maya Merabishvili, Jean‐Paul Pirnay, Gilbert Verbeken et al. · PLoS ONE · 2009 · 499 citations · Full text

Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens

Yves Briers, Maarten Walmagh, Victor Van Puyenbroeck et al. · mBio · 2014 · 387 citations · Full text

Engineering, Microbial Pathogens, Bacteriophage +17

Feeder layer- and animal product-free culture of neonatal foreskin keratinocytes: improved performance, usability, quality and safety

Peter Corte, Gunther Verween, Gilbert Verbeken et al. · Cell and Tissue Banking · 2011 · 55 citations · Full text

Cellular Pharmacodynamics of the Novel Biaryloxazolidinone Radezolid: Studies with Infected Phagocytic and Nonphagocytic cells, Using<i>Staphylococcus aureus</i>,<i>Staphylococcus epidermidis</i>,<i>Listeria monocytogenes</i>, and<i>Legionella pneumophila</i>

Sandrine Lemaire, Klaudia Kosowska-Shick, Peter C. Appelbaum et al. · Antimicrobial Agents and Chemotherapy · 2010 · 49 citations · Full text

Evaluation of a microbiological screening and acceptance procedure for cryopreserved skin allografts based on 14 day cultures

Jean‐Paul Pirnay, Gunther Verween, Bruno Pascual et al. · Cell and Tissue Banking · 2011 · 26 citations · Full text

Viable Donor Skin, Tissue Transplantation, Viable Skin +16